Training Activity References:
Ahijevych KL, Tyndale RF, Dhatt RK, Weed HG, Browning KK. Factors influencing cotinine half-life during smoking abstinence in African American and Caucasian women. Nicotine Tob Res. 2002; 4(4): 423-431.
Alcohol and Tobacco. Alcohol Research & Health. 2001; Vol 24, No 4: . Accessed on: 2010-08-12.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision. Washington, DC. American Psychiatric Association. 2000.
Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry. 1992; 149: 464-469.
Butler C, Rollnick S, Cohen D, Russell I, Bachmann M, Stott N. Motivational counseling versus brief advice for smokers in general practice: a randomized trial. Br J Gen Pract. 1999; 49: 611-616.
Carey KB. Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach. Community Mental Health Journal. 1996; 32: 291-306.
Centers for Disease Control and Prevention. Cigarette smoking among adults -- United States, 2002. MMWR Morb Mortal Wkly Rep. 2004; 53(20): 427-431.
Centers for Disease Control and Prevention. Cigarette smoking among adults -- United States, 2005. Morbidity and Mortality Weekly Report. 2006; 55(42): 1145-1148.
Centers for Disease Control and Prevention. Cigarette smoking among adults -- United States, 2005–2014. Morbidity and Mortality Weekly Report. 2007; 65(44): 1233-1240.
Centers for Disease Control and Prevention. Cigarette smoking among adults -- United States, 2007. Morbidity and Mortality Weekly Report. 2008; 57(45): 1221-1226.
Centers for Disease Control and Prevention. Cigarette use among high school students -- United States, 1991-2003. MMWR Morb Mortal Wkly Rep. 2004; 53(23): 499-502.
Centers for Disease Control and Prevention. Cigarette Use Among High School Students --- United States, 1991--2003. Morbidity and Mortality Weekly Report.
2004a; 200;53(23): 499-502. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5323a1.htm
Accessed on: 2006-02-23.
Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults in the United States. Smoking and Tobacco Use. CDCP Website. Content source: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion.
2016; December 1: . Available at: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/
Accessed on: 2017-01-09.
Centers for Disease Control and Prevention. Smoking & Tobacco Use. CDC Website.
2003. Available at: http://www.cdc.gov/tobacco/
Accessed on: 2010-06-15.
Centers for Disease Control and Prevention. Tobacco information and prevention source home page. CDC Website.
2003b. Available at: http://www.cdc.gov/tobacco/
Accessed on: 2003-08-11.
Centers for Disease Control and Prevention. Youth tobacco surveillance -- United States, 2000. Morbidity and Mortality Weekly Report. 2001; 50(SS04): 1-84.
Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease. FDA Safety Communication.
2011. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm259161.htm
Accessed on: 2011-07-05.
Cigarette Smoking Among Adults and Trends in Smoking Cessation --- United States, 2008. Morbidity and Mortality Weekly Report (MMWR). 2009; 58(44): 1227-1232.
Drug Facts and Comparisons. Drug Facts and Comparisons, 2003. St. Louis, Mo: Facts and Comparisons. 2003.
Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioural domains: a systematic review. Addiction. 2001; 96(12): 1725-1742.
Durcan MJ, Deener G, White J, et al. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics. 2002; 24(4): 540-551.
Emmons K, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med. 2001; 20(1): 68-74.
Evatt DP, Kassel JD. Smoking, arousal, and affect: The role of anxiety sensitivity
. Journal of Anxiety Disorders.
2010; 24: 114-123. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19819669
Accessed on: 2014-11-20.
Fertig JB. Overview-alcohol and tobacco: mechanisms and treatment. Alcoholism: Clinical & Experimental Research. 2002; 26(12): 1909-1910.
Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008.
GlaxoSmithKline. Nicotine Lozenge [package insert]. Research Triangle Park, NC. 2002.
Gonzales D, Rennard SI, Nides M, et al. Varenciline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA. 2006; 296(1): 47-55.
Gonzales D, Rennard SI,, Nides M, et al. Varenciline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA. 2006; 296(1): 47-55.
Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry. 2004; 61(11): 1107-1115.
Greenland S, Satterfield MH, Lanes SF. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety. 1998; 18(4): 297-308.
Haddock CK, Weg MV, DeBon M, et al. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Preventive Medicine. 2001; 32: 262-267.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9): 1119-1127.
Herrera N, Franco R, Herrera L, Partidas A, Rolando R, Fagerstrom KO. Nicotine gum, 2 and 4 mg, for nicotine dependence: a double-blind placebo-controlled trial within a behavior modification support program. Chest. 1995; 108: 447-451.
How to help your patients stop smoking- a National Cancer Institute manual for physicians. Smoking and Tobacco Control Program, National Cancer Institute, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. Bethesda, MD. 1998.
Ingersoll KS, Wagner CC, Gharib S. Motivational groups for community substance abuse programs. Mid-Atlantic Addiction Technology Transfer Center, Center for Substance Abuse Treatment. 2000.
Ingersoll KS, Wagner CC, Gharib S. Motivational groups for community substanceabuse programs. Mid-Atlantic Addiction Technology Transfer Center, Center for Substance Abuse Treatment. Richmond, VA. 2000.
Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial. JAMA. 2006; 296(1): 56-63.
King G, Polednak A, Bendel RB, Vilsaint MC, Nahata SB. Disparities in smoking cessation between African Americans and whites: 1990-2000. Am J Public Health. 2004; 94(11): 1965-1971.
Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000; 284(20): 2606-2610.
Leshner AI. Frontiers in neuroscience: the science of substance abuse: addiction is a brain disease, and it matters. Science. 1997; 278: 45-47.
Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996; 21: 779-88.
McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993; 270: 2207-2212.
Miller W. Motivational interviewing with problem drinkers. Behav Psychol. 1983; 11: 147-172.
Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. New York, NY; Guilford Press. 1991.
Moore MJ. The Transtheoretical Model of the Stages of Change and the Phases of Transformative Learning. Journal of Transformative Education.
2005; 3: 394-415. Available at: http://jtd.sagepub.com/content/3/4/394.short
Accessed on: 2014-09-18.
Morales-Suarez-Varela MM, Bille C, Christensen K, Olsen J. Smoking habits, nicotine use, and congenital malformations. Obstet Gynecol. 2006; 107(1): 51-57.
National Cancer Institute. Prevention and cessation of cigarette smoking: control of tobacco use. National Cancer Institute Website. 2003. Accessed on: 2003-05-26.
National Cancer Institute. Third International Conference on Smokeless Tobacco: Advancing Science & Protecting Public Health, Summary Report. Bethesda, Md: Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute. August 2003b.
Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, et al. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos. 2006; 34: 121-30.
Okuyemi KS, Ebersole-Robinson M, Nazir N, Ahluwalia JS. African-American menthol and nonmenthol smokers: differences in smoking and cessation experiences. J Natl Med Assoc. 2004; 96: 1208-1211.
PDR Staff. Physician's Desk Reference. Thomson Healthcare. 2003.
Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. American Psychologist. 1992; 47: 1102-1114.
Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychology. 1993; 12: 399-405.
Prochaska JO, Velicer WF, Fava JL, Rossi JS, Tsoh JY. Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation. Addictive Behaviors. 2001; 26: 583-602.
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. American Journal of Health Promotion. 1997; 12: 38-48.
Prokhorov AV, Hudmon KS, Stancic N. Adolescent smoking: epidemiology and approaches for achieving cessation. Pediatric Drugs. 2003; 5(1): 1-10.
Prokhorov AV, Warneke C, de Moor C, et al. Self-reported health status, health vulnerability, and smoking behavior in college students: implications for intervention. Nicotine and Tobacco Research. 2003; 5(4): 545-552.
Reynolds P, Hurley S, Goldberg DE,, et al. Active smoking, household passive smoking, and breast cancer: evidence from the California teachers study. J Natl Cancer Inst. 2004; 96(1): 29-37.
Rollnick S, Butler CC, Stott N. Helping smokers make decisions: the enhancement of brief interventions for general medical practice. Patient Educ Couns. 1997; 31: 191-203.
Rollnick S, Mason P, Butler C. Health behavior change: a guide for practitioners. Churchill Livingstone. 2003.
Rollnick S, Miller WR. What is motivational interviewing?. Behav Cognitive Psychother. 1995; 23: 325-334.
Rollnick S, Miller WR. What is motivational interviewing?. Behavioural and Cognitive Psychotherapy. 1995; 23: 325-334.
Rosengren D, Wagner CC. Motivational interviewing: shall we dance?. In: Coombs R, ed. Addiction Recovery Tools: A Practitioner's Handbook. Sage Publications. 2001.
Rubak S, Sandbæk A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. British Journal of General Pratice.
2005. Available at: http://bjgp.org/content/55/513/305
Accessed on: 2014-09-18.
Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction. 1996; 91: 1293-1306.
Shiffman CH, Jarvick ME. Smoking withdrawal symptoms in two weeks of abstinence. Journal of Psychopharmacology. 1976; 50(1): 35-39.
Shiffman S, Dresler CM, Hajek P, Gilburt SJA, Targett DA, Strahs KR. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med. 2002; 62: 1267-1276.
Siu AL, U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med.
2015. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26389730
Accessed on: 2016-02-09.
Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse?. Journal of Pharmacology and Experimental Therapeutics. 1998; 285: 931-945.
Smoking cessation treatment by primary care physicians: An update and call for training. American Journal of Preventive Medicine. 2006; 31(3): 233-239.
Smoking-related attitudes and clinical practices of medical personnel in Minnesota. American Journal of Preventive Medicine. 2004; 27(4): 316-322.
Sobell LC, Sobell MB, Agrawal S. Self-change and dual recoveries among individuals with alcohol and tobacco problems: current knowledge and future directions. Alcohol Clinical Experimental Research. 2002; (12): 1936-1938.
Stotts AL, Schmitz JM, Grabowski J. Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both?. Drug and Alcohol Dependence. 2003; 69: 1-7.
Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: National Academy Press, Institute of Medicine. 2001.
Tailoring tobacco counseling to the competing demands in the clinical encounter. Journal of Family Practice. 2001; 50(10): .
The Transtheoretical Model and Stages of Change. In: Glanz K, Rimer BK, Viswanath K, editors. Health Behavior and Health Education. 4th ed. 2008.
Tonstad S, Tonnesen P, Hajek P. Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial. JAMA. 2006; 296(1): 64-71.
Tran K, Asakawa K, Cimon K, et al. Pharmacologic-based strategies for smoking cessation: clinical and cost-effectiveness analyses. Canadian Agency for Drugs and Technologies in Health (CADTH). 2010; Sep:1: 548.
Unplanned quit attempts — results from a U.S. sample of smokers and ex-smokers. Nicotine & Tobacco. 2009; 11(7): 827–832. Accessed on: 2010-06-29.
US Bureau of the Census. National Cancer Institute Tobacco Use Supplement, Public Use Data Tapes, 1992-1993.. NIH. 1993.
US Dept of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Ga: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Dept of Health and Human Services. 2000.
US Dept of Health and Human Services. Smoking and Tobacco Control Monograph Number 2: Smokeless Tobacco or Health: An International Perspective.. Bethesda, Md: National Institutes of Health Public Health Service, US Dept of Health and Human Services, NIH Publication. 1992.
US Dept of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Dept of Health and Human Services.
2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/pdfs/executivesummary.pdf
Accessed on: 2004-12-17.
US Dept of Health and Human Services. Women and Smoking: A Report of the Surgeon General -- 2001. Atlanta, Ga: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Dept of Health and Human Services. 2001.
West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology.
2004; 177: 195-199. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15179542
Accessed on: 2014-09-22.
Wong LS, Green HM, Feugate JE, Yadav M, Nothnagel EA, Martins-Green M. Effects of "second-hand" smoke on structure and function of fibroblasts, cells that are critical for tissue repair and remodeling. BMC Cell Biol. 2004; 5(1): 13.
Woody D, DeCristofaro C, Carlton BG. Smoking cessation readiness: Are your patients ready to quit?
. J AM Acad Nurse Pract.
2008; 20: 407-14. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18786015
Accessed on: 2014-09-23.